{"recordsFiltered":50813,"recordsTotal":50813,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=40200","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=39600","results":[{"registry_id":"NCT03584022","publication_url":"https://clinicaltrials.gov/study/NCT03584022","title":"A Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial","has_exemption":false,"start_date":"2018-11-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04043442","publication_url":"https://clinicaltrials.gov/study/NCT04043442","title":"Neural Target Identification for Functional Disability Associated With Alcohol Related Characteristics Among Veterans With Co-occurring Alcohol Use Disorder and Traumatic Brain Injury","has_exemption":false,"start_date":"2019-01-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03321656","publication_url":"https://clinicaltrials.gov/study/NCT03321656","title":"Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile","has_exemption":false,"start_date":"2019-03-28","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Roberto Gedaly","sponsor_slug":"roberto-gedaly","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03878849","publication_url":"https://clinicaltrials.gov/study/NCT03878849","title":"Phase 2, Randomized, Prospective, Open-Label, Parallel-Arm, Dose Optimization Study to Investigate the Safety, Tolerability, PK/PD, and Anti- Tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer.","has_exemption":false,"start_date":"2019-04-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Allarity Therapeutics","sponsor_slug":"allarity-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03604991","publication_url":"https://clinicaltrials.gov/study/NCT03604991","title":"A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2019-05-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03786796","publication_url":"https://clinicaltrials.gov/study/NCT03786796","title":"Phase II Study of Olaparib in Metastatic Renal Cell Carcinoma Patients Harboring a BAP-1 or Other DNA Repair Gene Mutations (ORCHID)","has_exemption":false,"start_date":"2019-06-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03948490","publication_url":"https://clinicaltrials.gov/study/NCT03948490","title":"Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas","has_exemption":false,"start_date":"2019-06-07","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03946527","publication_url":"https://clinicaltrials.gov/study/NCT03946527","title":"Exploratory Phase II Study of LAnreotide in Metastatic Pheochromocytoma/PARAganglioma (LAMPARA)","has_exemption":false,"start_date":"2019-06-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Antonio Fojo","sponsor_slug":"antonio-fojo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04008797","publication_url":"https://clinicaltrials.gov/study/NCT04008797","title":"An Open-label Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors","has_exemption":false,"start_date":"2019-07-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04068597","publication_url":"https://clinicaltrials.gov/study/NCT04068597","title":"An Open-label Phase I/IIa Study to Evaluate the Safety and Efficacy of CCS1477 as Monotherapy and in Combination in Patients With Advanced Haematological Malignancies.","has_exemption":false,"start_date":"2019-08-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"CellCentric Ltd.","sponsor_slug":"cellcentric-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04077723","publication_url":"https://clinicaltrials.gov/study/NCT04077723","title":"An Open-Label, Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa (RO7227166, A CD19 Targeted 4-1BB Ligand) in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-treatment Dose of Obinutuzumab Administered in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2019-08-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04094311","publication_url":"https://clinicaltrials.gov/study/NCT04094311","title":"A Phase IIIb Study of the Safety and Efficacy of Tisagenlecleucel Out of Specification for Commercial Release in Patients Who Are Consistent With the Label Indication","has_exemption":false,"start_date":"2019-11-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03911505","publication_url":"https://clinicaltrials.gov/study/NCT03911505","title":"An Open-label Study of the Safety, Pharmacokinetics, Efficacy, Pharmacodynamics, and Immunogenicity of Cipaglucosidase Alfa/Miglustat in Pediatric Subjects Aged 0 to < 18 Years With Late-onset Pompe Disease","has_exemption":false,"start_date":"2020-02-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Amicus Therapeutics","sponsor_slug":"amicus-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04278781","publication_url":"https://clinicaltrials.gov/study/NCT04278781","title":"Phase II Study of AG-120 in IDH1 Mutant Chondrosarcoma","has_exemption":false,"start_date":"2020-03-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04329325","publication_url":"https://clinicaltrials.gov/study/NCT04329325","title":"Phase II Study of Blinatumomab and Concurrent Oral Tyrosine Kinase Inhibitor Therapy as Consolidation and Maintenance Therapy for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Following Chemotherapy-Sparing Induction","has_exemption":false,"start_date":"2020-03-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03836950","publication_url":"https://clinicaltrials.gov/study/NCT03836950","title":"rTMS as a Cognitive Rehabilitation Approach in Veterans With Parkinson's Disease","has_exemption":false,"start_date":"2020-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04310007","publication_url":"https://clinicaltrials.gov/study/NCT04310007","title":"A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC","has_exemption":false,"start_date":"2020-07-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03688178","publication_url":"https://clinicaltrials.gov/study/NCT03688178","title":"DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab","has_exemption":false,"start_date":"2020-08-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Annick Desjardins, MD","sponsor_slug":"annick-desjardins-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04444921","publication_url":"https://clinicaltrials.gov/study/NCT04444921","title":"A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients","has_exemption":false,"start_date":"2020-11-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04792073","publication_url":"https://clinicaltrials.gov/study/NCT04792073","title":"A Phase II Single-Arm Clinical Trial Assessing Comprehensive Ablative Radiation Therapy With Avelumab in Unresectable and Metastatic Merkel Cell Carcinoma (CARTA)","has_exemption":false,"start_date":"2021-03-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04591392","publication_url":"https://clinicaltrials.gov/study/NCT04591392","title":"Evaluation of the Safety and Efficacy of the reSept ASD Occluder to Treat Patients With Clinically Significant Secundum Atrial Septal Defect","has_exemption":false,"start_date":"2021-03-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"atHeart Medical","sponsor_slug":"atheart-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04800367","publication_url":"https://clinicaltrials.gov/study/NCT04800367","title":"Romosozumab for Premenopausal Idiopathic Osteoporosis","has_exemption":false,"start_date":"2021-03-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04784247","publication_url":"https://clinicaltrials.gov/study/NCT04784247","title":"A Pilot Study of Lenvatinib Plus Pembrolizumab in Patients With Advanced Sarcoma","has_exemption":false,"start_date":"2021-03-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04659811","publication_url":"https://clinicaltrials.gov/study/NCT04659811","title":"A Phase II Study of Stereotactic Radiosurgery in Conjunction With the PD-1 Inhibitor, Pembrolizumab for the Treatment of Recurrent Meningioma","has_exemption":false,"start_date":"2021-03-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Nancy Ann Oberheim Bush, MD","sponsor_slug":"nancy-ann-oberheim-bush-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04770610","publication_url":"https://clinicaltrials.gov/study/NCT04770610","title":"A Phase III, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Study of the Safety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in Pediatric Subjects","has_exemption":false,"start_date":"2021-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ocumension (Hong Kong) Limited","sponsor_slug":"ocumension-hong-kong-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04777357","publication_url":"https://clinicaltrials.gov/study/NCT04777357","title":"A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in Pediatric Subjects (10 to 17 Years of Age) in the Treatment of Depressive Episodes Associated With Bipolar I Disorder","has_exemption":false,"start_date":"2021-04-28","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04873362","publication_url":"https://clinicaltrials.gov/study/NCT04873362","title":"A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy","has_exemption":false,"start_date":"2021-05-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05680558","publication_url":"https://clinicaltrials.gov/study/NCT05680558","title":"THERAKOS® CELLEX Photopheresis System as an Interventional Therapy for the Treatment of Early Stage CTCL (Mycosis Fungoides), an Open-label, Single-arm, Multi-center, Phase II Study","has_exemption":false,"start_date":"2021-05-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04701476","publication_url":"https://clinicaltrials.gov/study/NCT04701476","title":"An Open Label Phase II Study for the Treatment of Liver Metastatic Colorectal Cancer and Non-Small Cell Lung Cancer With a Combination of TATE (Trans-Arterial Tirapazamine Embolization) and Pembrolizumab","has_exemption":false,"start_date":"2021-05-20","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Teclison Ltd.","sponsor_slug":"teclison-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05283811","publication_url":"https://clinicaltrials.gov/study/NCT05283811","title":"Mapping Algorithmic State Space in the Human Brain","has_exemption":false,"start_date":"2021-06-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04652908","publication_url":"https://clinicaltrials.gov/study/NCT04652908","title":"Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele","has_exemption":false,"start_date":"2021-06-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04951219","publication_url":"https://clinicaltrials.gov/study/NCT04951219","title":"A 52-Week, Phase 3, Open-Label Extension Study, With a Double-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)","has_exemption":false,"start_date":"2021-07-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Madrigal Pharmaceuticals, Inc.","sponsor_slug":"madrigal-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04995341","publication_url":"https://clinicaltrials.gov/study/NCT04995341","title":"Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study (BabySTEPS2)","has_exemption":false,"start_date":"2021-08-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05006716","publication_url":"https://clinicaltrials.gov/study/NCT05006716","title":"A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase Targeted Protein Degrader BGB-16673 in Patients With B-Cell Malignancies","has_exemption":false,"start_date":"2021-09-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05058976","publication_url":"https://clinicaltrials.gov/study/NCT05058976","title":"Innovative Approach to Geriatric Osteoporosis","has_exemption":false,"start_date":"2021-09-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Susan L. Greenspan","sponsor_slug":"susan-l-greenspan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04670640","publication_url":"https://clinicaltrials.gov/study/NCT04670640","title":"Mechanistic Interventions and Neuroscience of Dissociation","has_exemption":false,"start_date":"2021-09-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05058872","publication_url":"https://clinicaltrials.gov/study/NCT05058872","title":"Contraceptive Hormone and Reward Measurement (CHARM Study)","has_exemption":false,"start_date":"2021-10-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05124652","publication_url":"https://clinicaltrials.gov/study/NCT05124652","title":"An Automatically-adjusting Prosthetic Socket for People With Transtibial Amputation","has_exemption":false,"start_date":"2021-10-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04833894","publication_url":"https://clinicaltrials.gov/study/NCT04833894","title":"Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Efgartigimod in Children From 2 to Less Than 18 Years of Age With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2021-10-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03990896","publication_url":"https://clinicaltrials.gov/study/NCT03990896","title":"Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial","has_exemption":false,"start_date":"2021-11-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05197270","publication_url":"https://clinicaltrials.gov/study/NCT05197270","title":"A Phase 1/2 Dose-Escalation and Randomized, Controlled, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults With Neovascular (Wet) Age-Related Macular Degeneration","has_exemption":false,"start_date":"2021-12-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"4D Molecular Therapeutics","sponsor_slug":"4d-molecular-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05203939","publication_url":"https://clinicaltrials.gov/study/NCT05203939","title":"A Phase 1/2 Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa Associated With NR2E3 and RHO Mutations and Leber Congenital Amaurosis With Mutation(s) in CEP290 Gene","has_exemption":false,"start_date":"2022-01-24","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ocugen","sponsor_slug":"ocugen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05183854","publication_url":"https://clinicaltrials.gov/study/NCT05183854","title":"Phase II Study of the Efficacy of the Pneumococcal Pneumonia Vaccine Series in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency (PROTECT CLL)","has_exemption":false,"start_date":"2022-01-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05141721","publication_url":"https://clinicaltrials.gov/study/NCT05141721","title":"A Phase 2/3, Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-02-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Seattle Project Corporation","sponsor_slug":"seattle-project-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05239533","publication_url":"https://clinicaltrials.gov/study/NCT05239533","title":"A Phase 2 Open-label Study of Nivolumab Combined With Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients With Clear Cell Advanced Renal Cell Carcinoma","has_exemption":false,"start_date":"2022-02-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04226898","publication_url":"https://clinicaltrials.gov/study/NCT04226898","title":"A Double-Blind Placebo-Controlled Trial of the Synbiotic Compound Probio-Tec ABCG for Schizophrenia Patients With and Without Elevated Markers of Gastrointestinal Inflammation","has_exemption":false,"start_date":"2022-02-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Sheppard Pratt Health System","sponsor_slug":"sheppard-pratt-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04665037","publication_url":"https://clinicaltrials.gov/study/NCT04665037","title":"A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formulations in Pediatric Participants From Birth to Less Than 2 Years of Age With Possible, Probable, or Proven Invasive Fungal Infection","has_exemption":false,"start_date":"2022-02-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04647240","publication_url":"https://clinicaltrials.gov/study/NCT04647240","title":"A Two Part, Randomized Study of MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers","has_exemption":false,"start_date":"2022-02-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Merakris Therapeutics","sponsor_slug":"merakris-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05152888","publication_url":"https://clinicaltrials.gov/study/NCT05152888","title":"The Impact of Pcsk-9 Inhibition on PET Coronary Flow Reserve in Patients at High Cardiovascular Risk (EMPOWER Study)","has_exemption":false,"start_date":"2022-03-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05294120","publication_url":"https://clinicaltrials.gov/study/NCT05294120","title":"A Phase II Trial of Reflectance ConfocaL Microscopy And Optical Coherence Tomography Guided RadIation TherapY: CLARITY","has_exemption":false,"start_date":"2022-03-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04938765","publication_url":"https://clinicaltrials.gov/study/NCT04938765","title":"Randomized and Placebo Controlled Study to Evaluate the Effect of Magnesium Sulfate on Intraoperative Neuromonitoring.","has_exemption":false,"start_date":"2022-03-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05418894","publication_url":"https://clinicaltrials.gov/study/NCT05418894","title":"Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing","has_exemption":false,"start_date":"2022-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05309551","publication_url":"https://clinicaltrials.gov/study/NCT05309551","title":"The Effects of Inspiratory Muscle Training Immediatley After Lung Transplantation: a Randomized Controlled Trial","has_exemption":false,"start_date":"2022-04-20","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00775476","publication_url":"https://clinicaltrials.gov/study/NCT00775476","title":"Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine (NAC) (SNAC)","has_exemption":false,"start_date":"2022-05-05","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York - Upstate Medical University","sponsor_slug":"state-university-of-new-york-upstate-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05040360","publication_url":"https://clinicaltrials.gov/study/NCT05040360","title":"Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2022-05-05","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05199311","publication_url":"https://clinicaltrials.gov/study/NCT05199311","title":"A Phase I/II Study of Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Patients With Newly Diagnosed Transplant Eligible Multiple Myeloma","has_exemption":false,"start_date":"2022-05-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05271318","publication_url":"https://clinicaltrials.gov/study/NCT05271318","title":"A Two-part, Phase I/Ib, Open-Label, Dose-escalation Trial of Tumor Necrosis Factor Alpha and Interleukin-2 Coding Oncolytic Adenovirus (TILT-123) in Combination With Pembrolizumab (Phase I Part) and Pembrolizumab and Pegylated Liposomal Doxorubicin (Phase Ib Part) in Patients With Platinum Resistant or Refractory Ovarian Cancer","has_exemption":false,"start_date":"2022-05-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"TILT Biotherapeutics Ltd.","sponsor_slug":"tilt-biotherapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05186974","publication_url":"https://clinicaltrials.gov/study/NCT05186974","title":"An Open-label, Multicenter, Phase 2 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Without Actionable Genomic Alterations","has_exemption":false,"start_date":"2022-05-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05428969","publication_url":"https://clinicaltrials.gov/study/NCT05428969","title":"A Phase I/II Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of the Clever-1 Antibody Bexmarilimab in Combination With Standard of Care Therapy in Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia","has_exemption":false,"start_date":"2022-06-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Faron Pharmaceuticals Ltd","sponsor_slug":"faron-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565795","publication_url":"https://clinicaltrials.gov/study/NCT04565795","title":"URIPRENE: Clinical Study to Evaluate the Safety and Device Performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy","has_exemption":false,"start_date":"2022-07-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Adva-Tec","sponsor_slug":"adva-tec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05446272","publication_url":"https://clinicaltrials.gov/study/NCT05446272","title":"The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial","has_exemption":false,"start_date":"2022-08-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554692","publication_url":"https://clinicaltrials.gov/study/NCT05554692","title":"Peripheral and Central Contributions to Auditory Temporal Processing Deficits and Speech Understanding in Older Cochlear Implantees","has_exemption":false,"start_date":"2022-08-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, College Park","sponsor_slug":"university-of-maryland-college-park","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05451810","publication_url":"https://clinicaltrials.gov/study/NCT05451810","title":"A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma (Previously Grade 1-3a) When Administered in the Outpatient Setting","has_exemption":false,"start_date":"2022-08-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05443126","publication_url":"https://clinicaltrials.gov/study/NCT05443126","title":"A Modular, Open-label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0031 in Patients With Advanced RET-altered Malignancies","has_exemption":false,"start_date":"2022-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ellipses Pharma","sponsor_slug":"ellipses-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05305287","publication_url":"https://clinicaltrials.gov/study/NCT05305287","title":"Quantitation of Hepatic Mitochondrial Fluxes in Humans With Nonalcoholic Fatty Liver Disease (NAFLD)","has_exemption":false,"start_date":"2022-11-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519683","publication_url":"https://clinicaltrials.gov/study/NCT05519683","title":"Effects of Home-based TEA for Abdominal Pain in Patients With Irritable Bowel Syndrome (IBS)","has_exemption":false,"start_date":"2022-11-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444582","publication_url":"https://clinicaltrials.gov/study/NCT05444582","title":"Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start","has_exemption":false,"start_date":"2022-11-07","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05648500","publication_url":"https://clinicaltrials.gov/study/NCT05648500","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2022-12-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05681351","publication_url":"https://clinicaltrials.gov/study/NCT05681351","title":"An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)","has_exemption":false,"start_date":"2022-12-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05175196","publication_url":"https://clinicaltrials.gov/study/NCT05175196","title":"Microengineered Lollipop for Patient-Centric Saliva Collection","has_exemption":false,"start_date":"2023-01-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05653310","publication_url":"https://clinicaltrials.gov/study/NCT05653310","title":"Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional Dyspepsia","has_exemption":false,"start_date":"2023-02-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Xiao Jing (Iris) Wang","sponsor_slug":"xiao-jing-iris-wang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05778825","publication_url":"https://clinicaltrials.gov/study/NCT05778825","title":"A Pilot Study of Oral Minoxidil for the Treatment of Persistent Hair Loss in Pediatric, Adolescent, and Young Adult Cancer Survivors","has_exemption":false,"start_date":"2023-03-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05787574","publication_url":"https://clinicaltrials.gov/study/NCT05787574","title":"Phase 2 Study Bridging Pre-Transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)","has_exemption":false,"start_date":"2023-03-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Joseph Oved","sponsor_slug":"joseph-oved","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05787561","publication_url":"https://clinicaltrials.gov/study/NCT05787561","title":"Single Arm Phase II Study of Avutometinib (VS-6766) and Defactinib in Advanced or Recurrent Mesonephric Gynecologic Cancer","has_exemption":false,"start_date":"2023-03-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05543941","publication_url":"https://clinicaltrials.gov/study/NCT05543941","title":"Evaluating XPERIENCE™ Advanced Surgical Irrigation on Risk of Periprosthetic Joint Infection: A Multicenter Randomized Controlled Trial","has_exemption":false,"start_date":"2023-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ottawa Hospital Research Institute","sponsor_slug":"ottawa-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05900466","publication_url":"https://clinicaltrials.gov/study/NCT05900466","title":"Metformin as a Novel, Mechanistic Treatment of Fibromyalgia; a Proof of Concept RCT","has_exemption":false,"start_date":"2023-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05639647","publication_url":"https://clinicaltrials.gov/study/NCT05639647","title":"A PHASE 2A MULTICENTER, OBSERVER-BLINDED, RANDOMIZED 2 ARM STUDY TO INVESTIGATE PHARMACOKINETICS, SAFETY, TOLERABILITY AND EFFICACY OF INTRAVENOUS AZTREONAM-AVIBACTAM ± METRONIDAZOLE COMPARED TO BEST AVAILABLE THERAPY (BAT) IN PEDIATRIC PARTICIPANTS 9 MONTHS TO LESS THAN 18 YEARS OF AGE WITH SERIOUS GRAM-NEGATIVE BACTERIAL INFECTIONS INCLUDING COMPLICATED INTRA-ABDOMINAL INFECTION","has_exemption":false,"start_date":"2023-04-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05650723","publication_url":"https://clinicaltrials.gov/study/NCT05650723","title":"Zanubrutinib and Venetoclax as Initial Therapy for CLL With Obinutuzumab Consolidation in Patients With Minimal Residual Disease Positivity (BruVenG)","has_exemption":false,"start_date":"2023-05-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05877716","publication_url":"https://clinicaltrials.gov/study/NCT05877716","title":"EPI-MINN: Targeting Cognition and Motivation in Coordinated Specialty Care for Early Psychosis: A National Comparison Study","has_exemption":false,"start_date":"2023-05-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04877093","publication_url":"https://clinicaltrials.gov/study/NCT04877093","title":"Repurposing Low-Dose Clonidine for PTSD in Veterans","has_exemption":false,"start_date":"2023-06-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554133","publication_url":"https://clinicaltrials.gov/study/NCT05554133","title":"Precision Optical Guidance for Oral Biopsy Based on Next-Generation Hallmarks of Cancer (1R01DE029590-01): A Clinical Study to Evaluate and Optimize the Technical Performance Characteristics of an Active Biopsy Guidance System","has_exemption":false,"start_date":"2023-06-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05660746","publication_url":"https://clinicaltrials.gov/study/NCT05660746","title":"Precise Infliximab Exposure and Pharmacodynamic Control to Achieve Deep Remission in Pediatric Crohn's Disease","has_exemption":false,"start_date":"2023-07-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05843643","publication_url":"https://clinicaltrials.gov/study/NCT05843643","title":"SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects With Moderately to Severely Active SLE","has_exemption":false,"start_date":"2023-07-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06409559","publication_url":"https://clinicaltrials.gov/study/NCT06409559","title":"A Randomized Prospective Study Comparing Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws","has_exemption":false,"start_date":"2023-08-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05730205","publication_url":"https://clinicaltrials.gov/study/NCT05730205","title":"Effects of the Contraceptive Implant in Women With Sickle Cell Disease","has_exemption":false,"start_date":"2023-08-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05846230","publication_url":"https://clinicaltrials.gov/study/NCT05846230","title":"A Randomised, Double-blind, Parallel Group, Roll-over Study Evaluating Long-term Safety and Efficacy of Oral Doses of BI 1291583 q.d. in Patients With Bronchiectasis (Clairleafᵀᴹ)","has_exemption":false,"start_date":"2023-09-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05377905","publication_url":"https://clinicaltrials.gov/study/NCT05377905","title":"Phase Ib/II Study of Micro-needle Array Containing Doxorubicin in Immune Competent or Immune-suppressed Patients With Cutaneous Squamous Cell Carcinoma","has_exemption":false,"start_date":"2023-09-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Falo, Louis, MD","sponsor_slug":"falo-louis-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05957367","publication_url":"https://clinicaltrials.gov/study/NCT05957367","title":"A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies","has_exemption":false,"start_date":"2023-09-28","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Deciphera Pharmaceuticals LLC","sponsor_slug":"deciphera-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03929601","publication_url":"https://clinicaltrials.gov/study/NCT03929601","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","has_exemption":false,"start_date":"2023-10-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06163404","publication_url":"https://clinicaltrials.gov/study/NCT06163404","title":"A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant for Correction of Cartilaginous Nasal Septal Deviation","has_exemption":false,"start_date":"2023-11-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Spirair, Inc","sponsor_slug":"spirair-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05615844","publication_url":"https://clinicaltrials.gov/study/NCT05615844","title":"A Randomized Controlled Trial Comparing Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy for the Management of Severe Open Tibia Fracture Wounds","has_exemption":false,"start_date":"2023-11-05","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06063967","publication_url":"https://clinicaltrials.gov/study/NCT06063967","title":"A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Risankizumab Subcutaneous Induction Treatment in Subjects With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2023-11-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05411484","publication_url":"https://clinicaltrials.gov/study/NCT05411484","title":"Self-controlled, Single-site Trial Investigation of Laser Assisted Drug Delivery of NanoDOX®","has_exemption":false,"start_date":"2023-11-29","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06004674","publication_url":"https://clinicaltrials.gov/study/NCT06004674","title":"Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project (UPPPP Trial)","has_exemption":false,"start_date":"2023-12-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06163326","publication_url":"https://clinicaltrials.gov/study/NCT06163326","title":"A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTICENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO","has_exemption":false,"start_date":"2024-01-19","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06046248","publication_url":"https://clinicaltrials.gov/study/NCT06046248","title":"Phase II Trial of Belumosudil and Rituximab for the Primary Treatment of Extensive Chronic Graft-versus-host Disease","has_exemption":false,"start_date":"2024-01-29","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Northside Hospital, Inc.","sponsor_slug":"northside-hospital-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776056","publication_url":"https://clinicaltrials.gov/study/NCT05776056","title":"Randomized Placebo-Controlled Trial of Methylphenidate for the Treatment of Post-Traumatic Stress Disorder With Associated Neurocognitive Complaints","has_exemption":false,"start_date":"2024-02-05","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06199531","publication_url":"https://clinicaltrials.gov/study/NCT06199531","title":"A Phase 1/2/3 Open-label, Single Arm, Dose-finding Study to Investigate Long-term Safety, Tolerability and Efficacy of GS-100, an Adeno-associated Virus Serotype 9 (AAV9) Vector-mediated Gene Transfer of Human NGLY1, in Patients With NGLY1 Deficiency","has_exemption":false,"start_date":"2024-02-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Grace Science, LLC","sponsor_slug":"grace-science-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05901519","publication_url":"https://clinicaltrials.gov/study/NCT05901519","title":"A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma","has_exemption":false,"start_date":"2024-02-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05762796","publication_url":"https://clinicaltrials.gov/study/NCT05762796","title":"Assessing the Efficacy of Alterations in Subcortical-Cortical Functional Connectivity From Transcranial Direct Current Stimulation in Older Children After Mild Traumatic Brain Injury","has_exemption":false,"start_date":"2024-02-20","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05889741","publication_url":"https://clinicaltrials.gov/study/NCT05889741","title":"Combining Stellate Ganglion Block With Prolonged Exposure for PTSD: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-02-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05879432","publication_url":"https://clinicaltrials.gov/study/NCT05879432","title":"Phase 2 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of LSALT Peptide for the Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery","has_exemption":false,"start_date":"2024-03-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Arch Biopartners Inc.","sponsor_slug":"arch-biopartners-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06334432","publication_url":"https://clinicaltrials.gov/study/NCT06334432","title":"A Phase 1/2, First-in-Human, Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-03-14","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Nuvation Bio, Inc.","sponsor_slug":"nuvation-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06375811","publication_url":"https://clinicaltrials.gov/study/NCT06375811","title":"Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis - A Prospective Clinical Trial","has_exemption":false,"start_date":"2024-03-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162494","publication_url":"https://clinicaltrials.gov/study/NCT06162494","title":"Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients","has_exemption":false,"start_date":"2024-03-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","sponsor_slug":"ann-robert-h-lurie-childrens-hospital-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100887","publication_url":"https://clinicaltrials.gov/study/NCT06100887","title":"A Phase 2 Study to Evaluate the Effect of EDG-5506 on Safety, Pharmacokinetics, and Biomarkers in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy","has_exemption":false,"start_date":"2024-03-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Edgewise Therapeutics, Inc.","sponsor_slug":"edgewise-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06401642","publication_url":"https://clinicaltrials.gov/study/NCT06401642","title":"A Study to Assess Effectiveness and Tolerability of Zavegepant as an Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications.","has_exemption":false,"start_date":"2024-03-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06298812","publication_url":"https://clinicaltrials.gov/study/NCT06298812","title":"A Prospective, Single-Arm, Multi-Center, Registry Post-Approval Study of Growth Modulation in the Treatment of Idiopathic Scoliosis With the REFLECT™ Scoliosis Correction System","has_exemption":false,"start_date":"2024-04-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Globus Medical Inc","sponsor_slug":"globus-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311773","publication_url":"https://clinicaltrials.gov/study/NCT06311773","title":"Pivotal Multicenter Trial of the Boomerang® Catheter for Percutaneous Deep Vein Arterialization (pDVA)","has_exemption":false,"start_date":"2024-04-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Aveera Medical, Inc.","sponsor_slug":"aveera-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06059664","publication_url":"https://clinicaltrials.gov/study/NCT06059664","title":"The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study","has_exemption":false,"start_date":"2024-04-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05802004","publication_url":"https://clinicaltrials.gov/study/NCT05802004","title":"The Effect of Acoustic Enhancement of Slow-Wave Activity on Cognitive Control and Emotional Reactivity in Young Adults With Anxiety and Depression Symptoms","has_exemption":false,"start_date":"2024-04-24","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Michelle Stepan","sponsor_slug":"michelle-stepan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053606","publication_url":"https://clinicaltrials.gov/study/NCT06053606","title":"The Impact of Cryoablation Using Expandable (POLARxFIT) vs. Standard Size (POLARx) Balloon on Autonomic Control of the Heart","has_exemption":false,"start_date":"2024-05-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Wroclaw Medical University","sponsor_slug":"wroclaw-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05810259","publication_url":"https://clinicaltrials.gov/study/NCT05810259","title":"Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life Via a Randomized Control Trial","has_exemption":false,"start_date":"2024-05-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06167655","publication_url":"https://clinicaltrials.gov/study/NCT06167655","title":"A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM IN RELIEVING, INTERRUPTING, AND PREVENTING CHRONIC MIGRAINE (RELIEV-CM2)","has_exemption":false,"start_date":"2024-05-29","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"ShiraTronics","sponsor_slug":"shiratronics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06122584","publication_url":"https://clinicaltrials.gov/study/NCT06122584","title":"Prospective, Multi-Center Study to Assess the Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer","has_exemption":false,"start_date":"2024-06-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"ABX advanced biochemical compounds GmbH","sponsor_slug":"abx-advanced-biochemical-compounds-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06064097","publication_url":"https://clinicaltrials.gov/study/NCT06064097","title":"A Phase 2 Study Using Chemoimmunotherapy With Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)","has_exemption":false,"start_date":"2024-06-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06253507","publication_url":"https://clinicaltrials.gov/study/NCT06253507","title":"A Phase I/II, Non-Randomized, Open-Label Study of pCCLCHIM-p47 (Lentiviral Vector Transduced CD34+ Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)","has_exemption":false,"start_date":"2024-06-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05958342","publication_url":"https://clinicaltrials.gov/study/NCT05958342","title":"CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial","has_exemption":false,"start_date":"2024-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06466135","publication_url":"https://clinicaltrials.gov/study/NCT06466135","title":"Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of WAL0921 in Patients With Glomerular Kidney Diseases and Proteinuria","has_exemption":false,"start_date":"2024-07-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Walden Biosciences","sponsor_slug":"walden-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06456580","publication_url":"https://clinicaltrials.gov/study/NCT06456580","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-07-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Vor Biopharma","sponsor_slug":"vor-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06427941","publication_url":"https://clinicaltrials.gov/study/NCT06427941","title":"A Phase 1/2 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Selected Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2024-07-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06378346","publication_url":"https://clinicaltrials.gov/study/NCT06378346","title":"GU-01: Glycyrrhizin in Prostate Cancer: A Window-of-Opportunity Trial","has_exemption":false,"start_date":"2024-07-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411223","publication_url":"https://clinicaltrials.gov/study/NCT06411223","title":"Project Tara: Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06506942","publication_url":"https://clinicaltrials.gov/study/NCT06506942","title":"The TRICURE EFS TRiCares Topaz Transfemoral TRICUspid Heart Valve REplacement System Early Feasibility Study","has_exemption":false,"start_date":"2024-09-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"TRiCares","sponsor_slug":"tricares","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616207","publication_url":"https://clinicaltrials.gov/study/NCT06616207","title":"Efficacy and Safety of Topical 10% Povidone-Iodine in Preventing White Spots During Orthodontic Treatment","has_exemption":false,"start_date":"2024-09-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06539936","publication_url":"https://clinicaltrials.gov/study/NCT06539936","title":"Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses","has_exemption":false,"start_date":"2024-09-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Infinite Biomedical Technologies","sponsor_slug":"infinite-biomedical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06567743","publication_url":"https://clinicaltrials.gov/study/NCT06567743","title":"A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)","has_exemption":false,"start_date":"2024-09-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"CG Oncology, Inc.","sponsor_slug":"cg-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06375278","publication_url":"https://clinicaltrials.gov/study/NCT06375278","title":"Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation","has_exemption":false,"start_date":"2024-09-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Restorear Devices LLC","sponsor_slug":"restorear-devices-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554406","publication_url":"https://clinicaltrials.gov/study/NCT05554406","title":"A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7 + 3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who Are Considered High-Risk (Adverse) Acute Myeloid Leukemia As Determined by MYELOMATCH; A MYELOMATCH SubStudy","has_exemption":false,"start_date":"2024-09-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06044311","publication_url":"https://clinicaltrials.gov/study/NCT06044311","title":"A Window of Opportunity Trial Evaluating the Oral TGF-beta Receptor I Inhibitor Vactosertib in Patients Undergoing Standard of Care Chemoradiotherapy for Locally Advanced Esophageal Adenocarcinoma","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Melissa Lumish","sponsor_slug":"melissa-lumish","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610877","publication_url":"https://clinicaltrials.gov/study/NCT06610877","title":"Ultrasound Neuromodulation in Essential Tremor","has_exemption":false,"start_date":"2024-10-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483230","publication_url":"https://clinicaltrials.gov/study/NCT06483230","title":"A Pilot Study on Tolerance and Ease of Implementation of Intensive Visual Stimulation (IVS3) in Daily Practice for Upper Limb Motor Recovery in Outpatient Rehab Center","has_exemption":false,"start_date":"2024-10-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06559891","publication_url":"https://clinicaltrials.gov/study/NCT06559891","title":"A Pivotal, Prospective, Multicenter, 2:1 Randomized, Double Blind, Controlled, Study Comparing the THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension (The THRIVE Study)","has_exemption":false,"start_date":"2024-10-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"SoniVie Inc.","sponsor_slug":"sonivie-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06295471","publication_url":"https://clinicaltrials.gov/study/NCT06295471","title":"A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a Difference Frequency Generation (DFG) Laser and Carbon Dioxide (CO2) Laser","has_exemption":false,"start_date":"2024-10-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06602193","publication_url":"https://clinicaltrials.gov/study/NCT06602193","title":"A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)","has_exemption":false,"start_date":"2024-10-24","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Denali Therapeutics Inc.","sponsor_slug":"denali-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06117306","publication_url":"https://clinicaltrials.gov/study/NCT06117306","title":"MDMA-assisted Massed Prolonged Exposure for PTSD","has_exemption":false,"start_date":"2024-10-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Healing Breakthrough","sponsor_slug":"healing-breakthrough","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06515990","publication_url":"https://clinicaltrials.gov/study/NCT06515990","title":"A Phase I/IIa, Multicenter, Open-label, First-in-human, Dose Escalation and Expansion Study of DM005 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-10-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Doma Biopharmaceutical（Suzhou）Co., Ltd.","sponsor_slug":"doma-biopharmaceuticalsuzhouco-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06359782","publication_url":"https://clinicaltrials.gov/study/NCT06359782","title":"A Phase II Trial on the Safety and Efficacy of C1 Inhibitor for the Acute Management of Subarachnoid Hemorrhage","has_exemption":false,"start_date":"2024-11-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Haaglanden Medical Centre","sponsor_slug":"haaglanden-medical-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655155","publication_url":"https://clinicaltrials.gov/study/NCT06655155","title":"A Randomized, Double-Blinded, Placebo-Controlled, Phase 2, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Systemic Sclerosis","has_exemption":false,"start_date":"2024-11-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06382012","publication_url":"https://clinicaltrials.gov/study/NCT06382012","title":"Antiemetic Fosaprepitant To Remedy Nausea and Vomiting","has_exemption":false,"start_date":"2024-11-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06044675","publication_url":"https://clinicaltrials.gov/study/NCT06044675","title":"A Randomized Trial of MDMA-Assisted Cognitive-Behavioural Conjoint Therapy (CBCT) Versus CBCT in Dyads in Which One Member Has Posttraumatic Stress Disorder (PTSD)","has_exemption":false,"start_date":"2024-11-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Remedy","sponsor_slug":"remedy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526858","publication_url":"https://clinicaltrials.gov/study/NCT06526858","title":"A Prospective, Multicenter, Single Arm, Open-label, Early Feasibility Study to Evaluate Initial Safety and Device Design Concept of \"HyperQureTM RDN System\", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension on Three(3) or More Antihypertensive Medications","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"DeepQure Inc.","sponsor_slug":"deepqure-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668805","publication_url":"https://clinicaltrials.gov/study/NCT06668805","title":"A Phase 2, Randomized, Multicenter, Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment","has_exemption":false,"start_date":"2024-11-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05587361","publication_url":"https://clinicaltrials.gov/study/NCT05587361","title":"Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms","has_exemption":false,"start_date":"2024-11-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06667453","publication_url":"https://clinicaltrials.gov/study/NCT06667453","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of PGN-EDODM1 in Adult Participants With Myotonic Dystrophy Type 1 (FREEDOM2-DM1)","has_exemption":false,"start_date":"2024-12-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"PepGen Inc","sponsor_slug":"pepgen-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828939","publication_url":"https://clinicaltrials.gov/study/NCT06828939","title":"Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant Pulsed Field Ablation Balloon for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2024-12-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712407","publication_url":"https://clinicaltrials.gov/study/NCT06712407","title":"An Open-label Study to Assess the Efficacy and Safety of Extended TARPEYO® (Delayed-release Budesonide Capsules) Treatment in Adult Patients With Primary IgA Nephropathy Who Have Completed 9 Months of TARPEYO® 16 mg Once Daily Treatment in Real-world Clinical Practice","has_exemption":false,"start_date":"2024-12-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Calliditas Therapeutics AB","sponsor_slug":"calliditas-therapeutics-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06729632","publication_url":"https://clinicaltrials.gov/study/NCT06729632","title":"Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss","has_exemption":false,"start_date":"2024-12-19","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Restorear Devices LLC","sponsor_slug":"restorear-devices-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06632951","publication_url":"https://clinicaltrials.gov/study/NCT06632951","title":"A Phase 2, Open-Label, Randomized Study of Livmoniplimab in Combination With Budigalimab Versus Chemotherapy in Subjects With Metastatic Urothelial Carcinoma","has_exemption":false,"start_date":"2025-01-20","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06777316","publication_url":"https://clinicaltrials.gov/study/NCT06777316","title":"A Phase 1/2 Study of a Selective FGFR2/3 Inhibitor, CGT4859, in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors Harboring FGFR2 and/or FGFR3 Genetic Alterations","has_exemption":false,"start_date":"2025-01-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Cogent Biosciences, Inc.","sponsor_slug":"cogent-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05774665","publication_url":"https://clinicaltrials.gov/study/NCT05774665","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","has_exemption":false,"start_date":"2025-01-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05232032","publication_url":"https://clinicaltrials.gov/study/NCT05232032","title":"Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)","has_exemption":false,"start_date":"2025-02-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616025","publication_url":"https://clinicaltrials.gov/study/NCT06616025","title":"Phase 3, Multicenter, Randomized, Subject and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care (Neurorrhaphy) in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair.","has_exemption":false,"start_date":"2025-02-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Neuraptive Therapeutics Inc.","sponsor_slug":"neuraptive-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850974","publication_url":"https://clinicaltrials.gov/study/NCT06850974","title":"Foley Balloon for Cervical Preparation Before Dilation and Evacuation","has_exemption":false,"start_date":"2025-02-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06195241","publication_url":"https://clinicaltrials.gov/study/NCT06195241","title":"The Safety and Efficacy of DaxibotulinumtoxinA-Lanm for Benign Essential Blepharospasm and Hemifacial Spasm","has_exemption":false,"start_date":"2025-02-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616844","publication_url":"https://clinicaltrials.gov/study/NCT06616844","title":"Evaluating the Efficacy of Porcine Placental Extracellular Matrix Augmented Wound Care Against Standard Wound Care for the Management of Diabetic Foot Ulcers: A Multi-center, Prospective, Observer-blinded, Randomized Controlled Clinical Trial.","has_exemption":false,"start_date":"2025-02-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"ConvaTec Inc.","sponsor_slug":"convatec-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727565","publication_url":"https://clinicaltrials.gov/study/NCT06727565","title":"VELOCITY-HNSCC Substudy-01: A Phase 2 Study of Novel Combination Therapies in Participants With Previously Untreated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status","has_exemption":false,"start_date":"2025-02-18","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06795451","publication_url":"https://clinicaltrials.gov/study/NCT06795451","title":"Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains","has_exemption":false,"start_date":"2025-02-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660732","publication_url":"https://clinicaltrials.gov/study/NCT06660732","title":"A RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)","has_exemption":false,"start_date":"2025-03-05","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716814","publication_url":"https://clinicaltrials.gov/study/NCT06716814","title":"A Multinational, Prospective, Open-label, Roll-over Study (LIBERTY) to Provide Post-trial Access to Treatment for Patients With Haemophilia A Who Have Completed a Previous Trial With Efanesoctocog Alfa","has_exemption":false,"start_date":"2025-03-06","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06873815","publication_url":"https://clinicaltrials.gov/study/NCT06873815","title":"A Single-Arm Prospective Trial of Fluorescein Mapping in Patients Undergoing Vulvectomy for Extramammary Paget's Disease","has_exemption":false,"start_date":"2025-03-07","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915246","publication_url":"https://clinicaltrials.gov/study/NCT06915246","title":"A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)","has_exemption":false,"start_date":"2025-03-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"VIVUS LLC","sponsor_slug":"vivus-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06816498","publication_url":"https://clinicaltrials.gov/study/NCT06816498","title":"An Open-label, Single-center, Single-participant Study of an Experimental Antisense Oligonucleotide Treatment for a Patient With LMNB1 Mutation Associated Autosomal Dominant Leukodystrophy (ADLD)","has_exemption":false,"start_date":"2025-03-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810544","publication_url":"https://clinicaltrials.gov/study/NCT06810544","title":"A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG456 Monotherapy and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss","has_exemption":false,"start_date":"2025-03-24","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Tango Therapeutics, Inc.","sponsor_slug":"tango-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06749054","publication_url":"https://clinicaltrials.gov/study/NCT06749054","title":"A Phase 2, Open-label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Long-Acting Lenacapavir in Combination With an Optimized Background Regimen in Treatment-experienced Adolescents and Children With HIV-1","has_exemption":false,"start_date":"2025-03-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06891560","publication_url":"https://clinicaltrials.gov/study/NCT06891560","title":"Phase II Trial of Enfortumab Vedotin in Recurrent and/or Metastatic Adenoid Cystic Carcinoma","has_exemption":false,"start_date":"2025-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04383808","publication_url":"https://clinicaltrials.gov/study/NCT04383808","title":"Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06620029","publication_url":"https://clinicaltrials.gov/study/NCT06620029","title":"A Phase 1/2, Open-label Clinical Trial to Evaluate Safety and Efficacy of Combination Paclitaxel and BMX-001, in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"BioMimetix JV, LLC","sponsor_slug":"biomimetix-jv-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06757075","publication_url":"https://clinicaltrials.gov/study/NCT06757075","title":"A Comparison of Standard Dose of Ibuprofen Alone, Alternating, or Combined With Acetaminophen for the Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia","has_exemption":false,"start_date":"2025-04-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Boston University","sponsor_slug":"boston-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06949826","publication_url":"https://clinicaltrials.gov/study/NCT06949826","title":"A Single-institution, Parallel, Double-blinded, Randomized Study Assessing the Safety and Efficacy of Transdermal Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery","has_exemption":false,"start_date":"2025-04-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Jenna-Leigh Wilson","sponsor_slug":"jenna-leigh-wilson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06825260","publication_url":"https://clinicaltrials.gov/study/NCT06825260","title":"Polyethylene Glycol 3350 Compared With Senna After Urogynecologic Surgery A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-04-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Health, New York","sponsor_slug":"st-josephs-health-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06921928","publication_url":"https://clinicaltrials.gov/study/NCT06921928","title":"A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD4360 in Adult Participants With Advanced Solid Tumours","has_exemption":false,"start_date":"2025-04-29","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06920147","publication_url":"https://clinicaltrials.gov/study/NCT06920147","title":"PRevention Of Trauma-related Infections Through an Embedded Clinical Trials (PROTECT) Network","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662162","publication_url":"https://clinicaltrials.gov/study/NCT06662162","title":"Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration (i-SIGHT2): a Multicentre, Randomised, Sham-controlled, Double-masked, Clinical Device Trial.","has_exemption":false,"start_date":"2025-05-07","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"i-Lumen Scientific AUS PTY LTD","sponsor_slug":"i-lumen-scientific-aus-pty-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06873113","publication_url":"https://clinicaltrials.gov/study/NCT06873113","title":"Blood Flow Restriction Training for Subacromial Pain: A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2025-05-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223632","publication_url":"https://clinicaltrials.gov/study/NCT07223632","title":"The Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient With Confirmed IGHMBP2 Intronic Cryptic Splice Variant C. 1235+894C>A That is Amenable to Antisense Oligonucleotide (ASO)-Mediated Correction of IGHMBP2 Splicing","has_exemption":false,"start_date":"2025-05-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06903975","publication_url":"https://clinicaltrials.gov/study/NCT06903975","title":"The Effect of Injection of prabotulinumtoxinA-xvfs (Jeuveau) Into the Bilateral Sternocleidomastoid Muscles on Neck Circumference and Aesthetics","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06944509","publication_url":"https://clinicaltrials.gov/study/NCT06944509","title":"RADIQAL Study (Radiation Dose and Image Quality Trial)","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Philips Clinical & Medical Affairs Global","sponsor_slug":"philips-clinical-medical-affairs-global","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06672146","publication_url":"https://clinicaltrials.gov/study/NCT06672146","title":"A Randomized Phase II Trial of ASTX727 and Venetoclax Compared With ASTX727, Venetoclax, and Enasidenib for Newly Diagnosed Older Adults With IDH2 Mutant Acute Myeloid Leukemia: A MyeloMATCH Substudy","has_exemption":false,"start_date":"2025-05-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907849","publication_url":"https://clinicaltrials.gov/study/NCT06907849","title":"PET/CT Imaging Of Subjects With Lumbar Spinal Stenosis Or Carpal Tunnel Syndrome Using Amyloid-Reactive Peptide 124I-Evuzamitide","has_exemption":false,"start_date":"2025-05-22","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Tennessee Graduate School of Medicine","sponsor_slug":"university-of-tennessee-graduate-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06801041","publication_url":"https://clinicaltrials.gov/study/NCT06801041","title":"TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors","has_exemption":false,"start_date":"2025-05-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06872125","publication_url":"https://clinicaltrials.gov/study/NCT06872125","title":"EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Stoke Therapeutics, Inc","sponsor_slug":"stoke-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06944522","publication_url":"https://clinicaltrials.gov/study/NCT06944522","title":"exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease","has_exemption":false,"start_date":"2025-06-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"BlueRock Therapeutics","sponsor_slug":"bluerock-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07065240","publication_url":"https://clinicaltrials.gov/study/NCT07065240","title":"A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Adults With Major Depressive Disorder (MDD), With or Without Anxious Distress","has_exemption":false,"start_date":"2025-06-19","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Seaport Therapeutics","sponsor_slug":"seaport-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07074288","publication_url":"https://clinicaltrials.gov/study/NCT07074288","title":"Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives (OSANOVA): Comparison of Mandibular Advancement Device and Hypoglossal Nerve Stimulation Outcomes","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06803602","publication_url":"https://clinicaltrials.gov/study/NCT06803602","title":"Evaluating the Efficacy of High-Intensity Focused Electromagnetic Technology in Improving the Time of Recovery of Urinary Control of Continence and Quality of Life for Post-Surgical Patients","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06570473","publication_url":"https://clinicaltrials.gov/study/NCT06570473","title":"Feasibility Trial for the Canadian Right Ventricular AdaptiVE (CRAVE) Platform for Therapies Targeting Right Ventricular Failure","has_exemption":false,"start_date":"2025-07-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06963710","publication_url":"https://clinicaltrials.gov/study/NCT06963710","title":"A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects With Chronic Hepatitis B Virus Infection (B-SUPREME)","has_exemption":false,"start_date":"2025-07-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Aligos Therapeutics","sponsor_slug":"aligos-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679062","publication_url":"https://clinicaltrials.gov/study/NCT06679062","title":"A Double-masked, Randomized, Phase II Study to Compare the Effectiveness of 20mg Oral Suvorexant (SUV) Versus Placebo (1:1) in Participants With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)","has_exemption":false,"start_date":"2025-07-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Pharmacotherapies for Alcohol and Substance Use Disorders Alliance","sponsor_slug":"pharmacotherapies-for-alcohol-and-substance-use-disorders-alliance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06888921","publication_url":"https://clinicaltrials.gov/study/NCT06888921","title":"An Adaptive Clinical Platform Trial to Evaluate the Safety and Efficacy of COM701 as Monotherapy or Combination Therapy as Maintenance Therapy in Participants With Relapsed Platinum Sensitive Ovarian Cancer (PSOC)","has_exemption":false,"start_date":"2025-07-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Compugen Ltd","sponsor_slug":"compugen-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06129734","publication_url":"https://clinicaltrials.gov/study/NCT06129734","title":"Phase 1B/2A Study of Weekly Decitabine and Venetoclax Treatment as Maintenance Therapy in High-Risk Myeloid Malignancy Patients Post Allograft Stem Cell Transplant","has_exemption":false,"start_date":"2025-07-28","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Benjamin Tomlinson","sponsor_slug":"benjamin-tomlinson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06834035","publication_url":"https://clinicaltrials.gov/study/NCT06834035","title":"Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa","has_exemption":false,"start_date":"2025-08-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"M. Peter Marinkovich","sponsor_slug":"m-peter-marinkovich","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06774131","publication_url":"https://clinicaltrials.gov/study/NCT06774131","title":"A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel Formulation of UGN-101, for the Treatment of Patients With Low-grade Upper Tract Urothelial Cancer (LG-UTUC)","has_exemption":false,"start_date":"2025-08-06","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"UroGen Pharma Ltd.","sponsor_slug":"urogen-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07018700","publication_url":"https://clinicaltrials.gov/study/NCT07018700","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Episodic Migraine","has_exemption":false,"start_date":"2025-08-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Merz Therapeutics GmbH","sponsor_slug":"merz-therapeutics-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07018713","publication_url":"https://clinicaltrials.gov/study/NCT07018713","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Chronic Migraine","has_exemption":false,"start_date":"2025-08-21","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Merz Therapeutics GmbH","sponsor_slug":"merz-therapeutics-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06788964","publication_url":"https://clinicaltrials.gov/study/NCT06788964","title":"A Phase 2 Study of Loncastuximab Tesirine and Rituximab as Bridging Therapy Prior to Standard-of-care CD19 CAR T-cell Therapy in Patients With Large B-cell Lymphoma","has_exemption":false,"start_date":"2025-08-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095920","publication_url":"https://clinicaltrials.gov/study/NCT07095920","title":"Frequency-tuned Electromagnetic Field Treatment to Facilitate Recovery of Patients With Chronic Stroke","has_exemption":false,"start_date":"2025-08-27","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135427","publication_url":"https://clinicaltrials.gov/study/NCT07135427","title":"Genetic Variation in IgG as a Mechanism for Immune Deficiency and Exacerbations in AATD","has_exemption":false,"start_date":"2025-09-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07123727","publication_url":"https://clinicaltrials.gov/study/NCT07123727","title":"Single Arm Study to Evaluate the Safety of Nogapendekin Alfa Inbakicept (NAI) in Participants With Long COVID","has_exemption":false,"start_date":"2025-09-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06764966","publication_url":"https://clinicaltrials.gov/study/NCT06764966","title":"A Pilot Study of Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis","has_exemption":false,"start_date":"2025-09-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"CAMC Health System","sponsor_slug":"camc-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210125","publication_url":"https://clinicaltrials.gov/study/NCT07210125","title":"Implementation and Delivery of Lenacapavir for PrEP in a Community Pharmacy Setting","has_exemption":false,"start_date":"2025-09-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Kelley-Ross & Associates, Inc.","sponsor_slug":"kelley-ross-associates-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220460","publication_url":"https://clinicaltrials.gov/study/NCT07220460","title":"Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder","has_exemption":false,"start_date":"2025-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07175038","publication_url":"https://clinicaltrials.gov/study/NCT07175038","title":"A Phase 2A, Open-Label Single Arm Multicenter Exploratory Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Doses of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH).","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AllRock Bio, Inc.","sponsor_slug":"allrock-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06613568","publication_url":"https://clinicaltrials.gov/study/NCT06613568","title":"Prospective, Non-Randomized, Multicenter, Open-Label Study Evaluating the Use of the Moda-flx Hemodialysis System™ Under Professional Care and At Home by Participants With End Stage Kidney Disease (ESKD) Who Are on Stable Dialysis Regimens","has_exemption":false,"start_date":"2025-10-06","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Diality Inc.","sponsor_slug":"diality-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219121","publication_url":"https://clinicaltrials.gov/study/NCT07219121","title":"A Multicenter, Open-label Single Arm Study to Evaluate the Safety and Efficacy of Sparsentan in Posttransplant Immunoglobulin A Nephropathy (IgAN) or Focal Segmental Glomerulosclerosis (FSGS) (SPARX)","has_exemption":false,"start_date":"2025-10-07","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Travere Therapeutics, Inc.","sponsor_slug":"travere-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215559","publication_url":"https://clinicaltrials.gov/study/NCT07215559","title":"A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Reduction With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and With Type 2 Diabetes","has_exemption":false,"start_date":"2025-10-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07109739","publication_url":"https://clinicaltrials.gov/study/NCT07109739","title":"Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function","has_exemption":false,"start_date":"2025-10-24","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142356","publication_url":"https://clinicaltrials.gov/study/NCT07142356","title":"A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension","has_exemption":false,"start_date":"2025-10-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Retension Pharmaceuticals. Inc.","sponsor_slug":"retension-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918067","publication_url":"https://clinicaltrials.gov/study/NCT06918067","title":"Comparison of Urinary Flow Speed Using 14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter Versus 14 Fr Coloplast Micro Zone Luja Female Catheter in Female Patients Using Intermittent Catheters","has_exemption":false,"start_date":"2025-11-06","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07235085","publication_url":"https://clinicaltrials.gov/study/NCT07235085","title":"A Phase 3, Multicenter, Double-Masked, Randomized, 3-Arm Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTXTKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy","has_exemption":false,"start_date":"2025-11-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ocular Therapeutix, Inc.","sponsor_slug":"ocular-therapeutix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142291","publication_url":"https://clinicaltrials.gov/study/NCT07142291","title":"A Phase IIB Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Study to Evaluate the Effects of PHENOGENE-1A (Cromolyn) as an Adjuvant Treatment in Subjects With Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2025-11-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"PhenoNet, Inc.","sponsor_slug":"phenonet-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284810","publication_url":"https://clinicaltrials.gov/study/NCT07284810","title":"Tracking Reported Activities and Needs for Self-care, Function, Outcomes, Relief, and Mood","has_exemption":false,"start_date":"2025-11-26","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Cionic, Inc.","sponsor_slug":"cionic-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07236099","publication_url":"https://clinicaltrials.gov/study/NCT07236099","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2025-11-27","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Beijing InnoCare Pharma Tech Co., Ltd.","sponsor_slug":"beijing-innocare-pharma-tech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07395232","publication_url":"https://clinicaltrials.gov/study/NCT07395232","title":"A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Participants With Atopic Keratoconjunctivitis (AKC)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07269210","publication_url":"https://clinicaltrials.gov/study/NCT07269210","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 (Solbinsiran) in Adults With Severe Hypertriglyceridemia","has_exemption":false,"start_date":"2025-12-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287189","publication_url":"https://clinicaltrials.gov/study/NCT07287189","title":"A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Dose Comparison and Exploratory Efficacy Study of Orally Administered SAT-3247 in Ambulatory DMD Patients","has_exemption":false,"start_date":"2025-12-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Satellos Bioscience, Inc.","sponsor_slug":"satellos-bioscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06947928","publication_url":"https://clinicaltrials.gov/study/NCT06947928","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of IFx-Hu2.0 as an Adjunctive Therapy to Pembrolizumab in Checkpoint-Inhibitor Naïve Participants With Advanced or Metastatic Merkel Cell Carcinoma","has_exemption":false,"start_date":"2025-12-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"TuHURA Biosciences, Inc.","sponsor_slug":"tuhura-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07815678","publication_url":"https://clinicaltrials.gov/study/NCT07815678","title":"A Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food-effect of ACCG-2671","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics","sponsor_slug":"aconcagua-bio-inc-a-wholly-owned-subsidiary-of-structure-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07186725","publication_url":"https://clinicaltrials.gov/study/NCT07186725","title":"Home-Based Under-Mattress Monitoring Device to Estimate Mandibular Advancement in Oral Appliance Therapy for Obstructive Sleep Apnea","has_exemption":false,"start_date":"2026-01-07","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Isabel Moreno Hay","sponsor_slug":"isabel-moreno-hay","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07365826","publication_url":"https://clinicaltrials.gov/study/NCT07365826","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 Concomitantly Administered With Seasonal Influenza Vaccine in Healthy Subjects 50 Years of Age and Older","has_exemption":false,"start_date":"2026-01-12","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Vaxcyte, Inc.","sponsor_slug":"vaxcyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184619","publication_url":"https://clinicaltrials.gov/study/NCT07184619","title":"A Phase III, 12-week, Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Determine the Efficacy, Safety, and Tolerability of a Dose of 15 mg Bid of Evenamide as add-on in Patients With Documented Treatment-resistant Schizophrenia, Which is Not Adequately Controlled by a Stable Therapeutic Dose of the Patient's Current Antipsychotic Medication(s)","has_exemption":false,"start_date":"2026-01-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Newron Pharmaceuticals SPA","sponsor_slug":"newron-pharmaceuticals-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224321","publication_url":"https://clinicaltrials.gov/study/NCT07224321","title":"INHALE-1st: Technosphere Insulin (Afrezza®) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes","has_exemption":false,"start_date":"2026-02-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mannkind Corporation","sponsor_slug":"mannkind-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07304089","publication_url":"https://clinicaltrials.gov/study/NCT07304089","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (Stride Dystonia)","has_exemption":false,"start_date":"2026-02-05","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Vima Therapeutics","sponsor_slug":"vima-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07425392","publication_url":"https://clinicaltrials.gov/study/NCT07425392","title":"A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Subjects 50 Years of Age and Older With Prior Pneumococcal Vaccination","has_exemption":false,"start_date":"2026-02-09","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Vaxcyte, Inc.","sponsor_slug":"vaxcyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07328594","publication_url":"https://clinicaltrials.gov/study/NCT07328594","title":"Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking During Abstinence","has_exemption":false,"start_date":"2026-02-10","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Legacy Health System","sponsor_slug":"legacy-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06807593","publication_url":"https://clinicaltrials.gov/study/NCT06807593","title":"Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients","has_exemption":false,"start_date":"2026-02-24","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07455513","publication_url":"https://clinicaltrials.gov/study/NCT07455513","title":"A Pilot/Feasibility Study of the Buckeye Quit Stick: A Novel Resource for Successful Tobacco Cessation","has_exemption":false,"start_date":"2026-02-25","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07328555","publication_url":"https://clinicaltrials.gov/study/NCT07328555","title":"Site Randomized Clinical Trial of the Effect of Digital Otoscopy Versus Standard Otoscopy on the Diagnosis and Treatment of Otitis Media in Young Children","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285863","publication_url":"https://clinicaltrials.gov/study/NCT07285863","title":"An Open-Label Study On The Effects Of Human Secretin For Injection (CHIROSTIM) On Pancreatic Fluid Composition In Normal Human Volunteer Participants","has_exemption":false,"start_date":"2026-03-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290517","publication_url":"https://clinicaltrials.gov/study/NCT07290517","title":"The Carevix Device: Assessing Pain and Effectiveness of a Suction-based Cervical Stabilizer for IUD Insertions in the Clinic Setting: a Randomized, Controlled Trial (CARE)","has_exemption":false,"start_date":"2026-03-11","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07118358","publication_url":"https://clinicaltrials.gov/study/NCT07118358","title":"BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System","has_exemption":false,"start_date":"2026-03-16","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Biotronik, Inc.","sponsor_slug":"biotronik-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486882","publication_url":"https://clinicaltrials.gov/study/NCT07486882","title":"A Feasibility Pilot Comparing Acoustic Resonance Therapy (ART) to Cognitive Behavioral Therapy for Insomnia (CBT-I) for Treating Patients With Moderate to Severe Chronic Insomnia Disorder","has_exemption":false,"start_date":"2026-03-17","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286201","publication_url":"https://clinicaltrials.gov/study/NCT07286201","title":"A Multicenter, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of a Bioresorbable Nasal Dressing Containing Mometasone Furoate Compared to a Steroid-eluting Sinus Stent","has_exemption":false,"start_date":"2026-03-19","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Polyganics BV","sponsor_slug":"polyganics-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06841575","publication_url":"https://clinicaltrials.gov/study/NCT06841575","title":"Advancing Pediatric Retinal Imaging With Auto-aligned OCT","has_exemption":false,"start_date":"2026-03-23","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502495","publication_url":"https://clinicaltrials.gov/study/NCT07502495","title":"A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets Despite Antihyperglycemic Medications","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Biomea Fusion Inc.","sponsor_slug":"biomea-fusion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07427121","publication_url":"https://clinicaltrials.gov/study/NCT07427121","title":"Rehabilitation-based Approaches to Prevent Mechanical Ventilation-induced Breathing Dysfunction","has_exemption":false,"start_date":"2026-03-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07328529","publication_url":"https://clinicaltrials.gov/study/NCT07328529","title":"Safety, Tolerability, and Efficacy of SRX246, a Vasopressin 1a Receptor Antagonist, in Aggressive Participants With Fragile X Syndrome","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Azevan Pharmaceuticals","sponsor_slug":"azevan-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07385313","publication_url":"https://clinicaltrials.gov/study/NCT07385313","title":"Randomized Prospective Evaluation of Ovine Forestomach Matrix (OFM) and NPWT to Accelerate Tissue Coverage Over Exposed Structures","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Aroa Biosurgery Limited","sponsor_slug":"aroa-biosurgery-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07394894","publication_url":"https://clinicaltrials.gov/study/NCT07394894","title":"Local Percutaneous Pulsed Radiofrequency Ablation Versus Ultrasound Guided Steroids Injection in Management of Pain in Cases of Chronic Planter Fascitis, Randomised Double Blinded Study","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07423494","publication_url":"https://clinicaltrials.gov/study/NCT07423494","title":"An Open-label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis (ALS) Due to CHCHD10 Gene Mutation","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07440797","publication_url":"https://clinicaltrials.gov/study/NCT07440797","title":"EVALUATION OF THE EFFICACY AND TOLERANCE OF VASHE SOLUTION VERSUS SALINE SOLUTION IN THE TREATMENT OF VENOUS OR MIXED LEG ULCERS PRESENTING INFLAMMATORY SIGNS SUGGESTING HEAVY BACTERIAL LOAD: MULTICENTER, PROSPECTIVE, OPEN-LABEL, RANDOMIZED CONTROLLED TRIAL","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Laboratoires URGO","sponsor_slug":"laboratoires-urgo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485205","publication_url":"https://clinicaltrials.gov/study/NCT07485205","title":"Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Bright Uro","sponsor_slug":"bright-uro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07501338","publication_url":"https://clinicaltrials.gov/study/NCT07501338","title":"Early AID Pilot for Newly Diagnosed T1D","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07147179","publication_url":"https://clinicaltrials.gov/study/NCT07147179","title":"Pilot Trial of Short Course Radiotherapy for Primary or Secondary CNS Malignancies","has_exemption":false,"start_date":"2026-04-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502378","publication_url":"https://clinicaltrials.gov/study/NCT07502378","title":"Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency","has_exemption":false,"start_date":"2026-04-06","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of South Florida","sponsor_slug":"university-of-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447739","publication_url":"https://clinicaltrials.gov/study/NCT07447739","title":"Efficacy and Safety of Postnatal Betamethasone for Respiratory Weaning in Extremely Low Gestational Age Neonates (ELGANs) in a Prospective Cohort - Proof of Concept Pilot Study","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Khang Nguyen","sponsor_slug":"khang-nguyen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05199688","publication_url":"https://clinicaltrials.gov/study/NCT05199688","title":"A Phase III, Multicenter, Open-Label, Uncontrolled Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)","has_exemption":false,"start_date":"2026-05-06","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087536","publication_url":"https://clinicaltrials.gov/study/NCT06087536","title":"A Prospective, Multinational, Multicenter, Randomized, Sequential, Double-blind, Placebo-controlled, Phase 2a Clinical Trial to Assess the Safety and Pharmacokinetics of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex (ABC).","has_exemption":false,"start_date":"2026-05-14","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Omnix Medical Ltd","sponsor_slug":"omnix-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07646613","publication_url":"https://clinicaltrials.gov/study/NCT07646613","title":"A Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Clinical Trial for the Evaluation of Efficacy, Safety, and Tolerability of ASY202 for the Acute Treatment of Migraine in Adult Patients","has_exemption":false,"start_date":"2026-05-19","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Aspeya, Inc.","sponsor_slug":"aspeya-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226050","publication_url":"https://clinicaltrials.gov/study/NCT07226050","title":"A Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CLF065 in the Treatment of Chronic Pouchitis","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Calibr, a division of Scripps Research","sponsor_slug":"calibr-a-division-of-scripps-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07143838","publication_url":"https://clinicaltrials.gov/study/NCT07143838","title":"Investigating Slow Wave Sleep Enhancement to Improve Cognitive Function in Adults With Depression","has_exemption":false,"start_date":"2026-06-04","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07332143","publication_url":"https://clinicaltrials.gov/study/NCT07332143","title":"The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD","has_exemption":false,"start_date":"2026-06-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07504458","publication_url":"https://clinicaltrials.gov/study/NCT07504458","title":"A Pivotal Open-label Phase 3 Clinical Study Evaluating the Efficacy and Safety of QTX-2101 in Combination With All-trans Retinoic Acid in Newly Diagnosed, Low-risk Acute Promyelocytic Leukemia","has_exemption":false,"start_date":"2026-06-08","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Quetzal Therapeutics","sponsor_slug":"quetzal-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07450586","publication_url":"https://clinicaltrials.gov/study/NCT07450586","title":"Virtual Activities of Living for Occupational Rehabilitation (VALOR)","has_exemption":false,"start_date":"2026-06-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Barron Associates, Inc.","sponsor_slug":"barron-associates-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07632001","publication_url":"https://clinicaltrials.gov/study/NCT07632001","title":"A Randomized Controlled Multicenter Trial, Examining the Effect of Miro3D Wound Matrix on the Rate of Complete Wound Closure of Chronic Diabetic Foot Ulcers","has_exemption":false,"start_date":"2026-06-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Reprise Biomedical, Inc.","sponsor_slug":"reprise-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219797","publication_url":"https://clinicaltrials.gov/study/NCT07219797","title":"Study of Monochromatic X-ray Mammography System","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Imagine Scientific, Inc.","sponsor_slug":"imagine-scientific-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461935","publication_url":"https://clinicaltrials.gov/study/NCT07461935","title":"Early Feasibility Study of the Single Chamber ALPS Leadless Pacemaker System in Patients With Bradycardia","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Cairdac SA","sponsor_slug":"cairdac-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516106","publication_url":"https://clinicaltrials.gov/study/NCT07516106","title":"Prospective Multi-center Study Comparing Pulsed Tm:YAG Laser to Pulse Modulated Holmium Laser in the Treatment of Nephrolithiasis With Flexible And Navigable Ureteric Access Sheath (FANS)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135453","publication_url":"https://clinicaltrials.gov/study/NCT07135453","title":"Novel Serotype Alert: Investigate New Pneumococcal Conjugate Vaccines for Inducing Cross-protection Against Newly Discovered Serotype 33E and Putative Novel Serogroup 33 Serotypes","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06790095","publication_url":"https://clinicaltrials.gov/study/NCT06790095","title":"Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Part 3 - Option II","has_exemption":false,"start_date":"2026-07-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07453563","publication_url":"https://clinicaltrials.gov/study/NCT07453563","title":"Comparison of GlideScope and Airway Scope for Intubating Morbidly Obese Patients: A Randomized Controlled Study","has_exemption":false,"start_date":"2026-07-13","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07408557","publication_url":"https://clinicaltrials.gov/study/NCT07408557","title":"Adapting the Stanford Obstetric Recovery Checklist (STORK) to a Digital Health Platform: A Feasibility and User Feedback Study","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07604285","publication_url":"https://clinicaltrials.gov/study/NCT07604285","title":"A Phase 1/2 Dose Escalation and Randomized Expansion Study of Safety, Tolerability, and Pharmacokinetics of MT-125 Monotherapy With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Myosin Therapeutics Inc.","sponsor_slug":"myosin-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07650032","publication_url":"https://clinicaltrials.gov/study/NCT07650032","title":"Cryoablation for Monomorphic Ventricular Tachycardia IDE Study","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Adagio Medical","sponsor_slug":"adagio-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07802301","publication_url":"https://clinicaltrials.gov/study/NCT07802301","title":"Novel Pairing of taVNS and an Oral Sensorimotor Protocol in Infants With Severe Dysphagia","has_exemption":false,"start_date":"2026-08-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05106127","publication_url":"https://clinicaltrials.gov/study/NCT05106127","title":"A Phase 2, Open-Label, Safety Lead-In With Long Term Safety Study of EG-007, Added to the Combination of Lenvatinib Plus Pembrolizumab","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Evergreen Therapeutics, Inc.","sponsor_slug":"evergreen-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07731802","publication_url":"https://clinicaltrials.gov/study/NCT07731802","title":"Finasteride and Cutibacterium","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07561372","publication_url":"https://clinicaltrials.gov/study/NCT07561372","title":"Enhancing Speed and Accuracy of Motor Evoked Potential Recruitment Curve Analysis Using Hierarchical Bayesian Modeling","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07788703","publication_url":"https://clinicaltrials.gov/study/NCT07788703","title":"Validation of Non-invasive Spectrophotometric Haemoglobin (SpHb) Measurement for Detection of Anaemia and Observation of Trends in Infants Admitted to the Neonatal Intensive Care Unit (NICU): A Prospective Diagnostic Accuracy Study.","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Malaya","sponsor_slug":"university-of-malaya","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07776405","publication_url":"https://clinicaltrials.gov/study/NCT07776405","title":"Topical Cannabidiol for Plantar Fasciitis: A Double-Blinded Study on Rapid and Sustained Pain Relief","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225634","publication_url":"https://clinicaltrials.gov/study/NCT07225634","title":"An Open Label, Pharmacokinetic and Safety Study of Combogesic® IV in Pediatric Patients With Acute Pain","has_exemption":false,"start_date":"2026-09-14","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"AFT Pharmaceuticals, Ltd.","sponsor_slug":"aft-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07841119","publication_url":"https://clinicaltrials.gov/study/NCT07841119","title":"Comparison of Gingival Depigmentation Using a 940 nm GaAlAs Diode Laser and Ceramic Bur: A Split-Mouth Randomized Clinical Trial","has_exemption":false,"start_date":"2026-09-20","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Medicine and Pharmacy at Ho Chi Minh City","sponsor_slug":"university-of-medicine-and-pharmacy-at-ho-chi-minh-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07898072","publication_url":"https://clinicaltrials.gov/study/NCT07898072","title":"A Single-Blind, Single-Arm, Multiple-Dose Study Evaluating the Safety and Efficacy of Testosterone Cypionate Administered Subcutaneously Via a Weekly Auto-Injector in Adult Males With Hypogonadism Through Week 24","has_exemption":false,"start_date":"2026-09-28","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Amneal Pharmaceuticals, LLC","sponsor_slug":"amneal-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04563520","publication_url":"https://clinicaltrials.gov/study/NCT04563520","title":"aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07776210","publication_url":"https://clinicaltrials.gov/study/NCT07776210","title":"A Randomized, Double-Masked, Vehicle-Controlled, Adequate and Well-Controlled Pivotal Study With Co-Primary Endpoints to Evaluate the Safety and Efficacy of d-MAPPS™ Ophthalmic Solution in Subjects With Chronic Ocular Graft-Versus-Host Disease (oGVHD)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Regenerative Ocular Immunobiologics LLC","sponsor_slug":"regenerative-ocular-immunobiologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07801105","publication_url":"https://clinicaltrials.gov/study/NCT07801105","title":"A Prospective Adaptive Pilot Study of Serial Unstimulated Oocyte Retrieval and CAPA-IVM (Capacitation In Vitro Maturation) for Euploid Embryo Accumulation in Women With Robust Ovarian Reserve","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Kevin Doody","sponsor_slug":"kevin-doody","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07832422","publication_url":"https://clinicaltrials.gov/study/NCT07832422","title":"Effects of Ischemic Compression and Low-Level Laser Therapy in Combination With Exercise Versus Exercise Alone in Managing Myofascial Low Back Pain: A Randomized Controlled Study","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Nova Southeastern University","sponsor_slug":"nova-southeastern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07870837","publication_url":"https://clinicaltrials.gov/study/NCT07870837","title":"Head-to-Head Comparison of Ambulatory Cardiac ECG Monitors in Japan","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"iRhythm Technologies, Inc.","sponsor_slug":"irhythm-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04777500","publication_url":"https://clinicaltrials.gov/study/NCT04777500","title":"Applying Transcutaneous Auricular Vagus Nerve Stimulation to Treat Fibromyalgia","has_exemption":false,"start_date":"2026-10-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07856680","publication_url":"https://clinicaltrials.gov/study/NCT07856680","title":"Treatment of Fungal Blepharitis With Natacyn: A Prospective Interventional Study","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Brent Kramer","sponsor_slug":"brent-kramer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07858435","publication_url":"https://clinicaltrials.gov/study/NCT07858435","title":"A Within-Patient Comparison of CAPA-IVM (Biphasic Capacitation IVM) With the Contralateral Ovary Undergoing Minimal Controlled Ovarian Stimulation (OS-IVF)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"New Hope Fertility Center","sponsor_slug":"new-hope-fertility-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07874620","publication_url":"https://clinicaltrials.gov/study/NCT07874620","title":"A Randomized, Double-Blind, Multiple-Dose Study to Assess the Ability of Cebranopadol to Suppress Withdrawal Signs and Symptoms in Adults With Chronic Pain Who Are Physically Dependent on Opioids","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Adneuris Therapeutics, Inc.","sponsor_slug":"adneuris-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07894081","publication_url":"https://clinicaltrials.gov/study/NCT07894081","title":"Evaluation of Gixam's Repeatability and Reproducibility Predicting the Presence of Advanced and Non-Advanced Colorectal Neoplasia","has_exemption":false,"start_date":"2026-11-02","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Jubaan Ltd.","sponsor_slug":"jubaan-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02046330","publication_url":"https://clinicaltrials.gov/study/NCT02046330","title":"Deep Brain Stimulation (DBS) Therapy for Treatment Resistant","has_exemption":false,"start_date":"2013-12-16","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01953588","publication_url":"https://clinicaltrials.gov/study/NCT01953588","title":"ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study","has_exemption":false,"start_date":"2014-02-27","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02231775","publication_url":"https://clinicaltrials.gov/study/NCT02231775","title":"Neoadjuvant and Adjuvant Dabrafenib and Trametinib in Patients With Clinical Stage III Melanoma (Combi-Neo)","has_exemption":false,"start_date":"2014-10-22","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02484248","publication_url":"https://clinicaltrials.gov/study/NCT02484248","title":"Double-blind, Placebo-controlled, Cross-over Trial of Ketotifen in Children and Adolescents With Functional Dyspepsia in Association With Duodenal Eosinophilia","has_exemption":false,"start_date":"2015-08-31","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Craig A. Friesen, MD","sponsor_slug":"craig-a-friesen-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03410043","publication_url":"https://clinicaltrials.gov/study/NCT03410043","title":"Randomized Phase II Trial of Osimertinib With or Without Local Consolidation Therapy (LCT) for Patients With EGFR-Mutant Metastatic NSCLC (NORTHSTAR)","has_exemption":false,"start_date":"2018-01-17","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03574571","publication_url":"https://clinicaltrials.gov/study/NCT03574571","title":"Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2018-06-19","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04263025","publication_url":"https://clinicaltrials.gov/study/NCT04263025","title":"Prospective, Controlled Study Evaluating Recovery of Potency and Continence Following Robot-Assisted Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft","has_exemption":false,"start_date":"2020-01-30","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04332874","publication_url":"https://clinicaltrials.gov/study/NCT04332874","title":"A Phase II Study of Concurrent Systemic Pembrolizumab and Isolated Limb Infusion (ILI) With Melphalan and Dactinomycin for Patients With Locally Advanced or Metastatic Extremity Sarcoma","has_exemption":false,"start_date":"2020-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04468061","publication_url":"https://clinicaltrials.gov/study/NCT04468061","title":"Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2020-07-20","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04735263","publication_url":"https://clinicaltrials.gov/study/NCT04735263","title":"Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD","has_exemption":false,"start_date":"2021-02-04","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04693377","publication_url":"https://clinicaltrials.gov/study/NCT04693377","title":"Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases","has_exemption":false,"start_date":"2021-03-16","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04701684","publication_url":"https://clinicaltrials.gov/study/NCT04701684","title":"WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)","has_exemption":false,"start_date":"2021-06-23","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Philips Clinical & Medical Affairs Global","sponsor_slug":"philips-clinical-medical-affairs-global","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04929210","publication_url":"https://clinicaltrials.gov/study/NCT04929210","title":"A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease","has_exemption":false,"start_date":"2021-08-30","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05108818","publication_url":"https://clinicaltrials.gov/study/NCT05108818","title":"Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults","has_exemption":false,"start_date":"2021-10-07","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04835129","publication_url":"https://clinicaltrials.gov/study/NCT04835129","title":"A Multisite, Phase II Study of Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-01-10","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04859946","publication_url":"https://clinicaltrials.gov/study/NCT04859946","title":"Itacitinib to Prevent Graft Versus Host Disease","has_exemption":false,"start_date":"2022-01-11","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04899687","publication_url":"https://clinicaltrials.gov/study/NCT04899687","title":"Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot Study","has_exemption":false,"start_date":"2022-01-20","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null}]}